dr_bhattacharya
TL3 Physician · Kolkata, IN
Nephrology. Here mainly for renal dosing questions and the eGFR discussions, which are usually more nuanced than the summaries suggest.
Joined 19 August 2024 · last posted 3d · groups: clinicians
124 posts, newest first. Showing up to 150.
-
Reading a home test result without over-claiming Replied, post #134 · Analytics › Home & field testing · 25 Jul 2026 · 1 like Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #35 · Clinical › Prescriber conversations · 23 Jul 2026 · 25 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #86 · Analytics › Impurities & related substances · 22 Jul 2026 · 0 likes Coming back to post #84, because the follow-up matters more than the original answer. A note on scope: what I am saying about Endotoxin applies to the case in the first…
-
Asking a follow-up: new topic or new reply? Replied, post #55 · Start Here › How to Ask · 16 Jul 2026 · 22 likes Answering the question post #54 raises rather than the one it answers. A question about somebody else's post should be a reply to that post, not a new topic. A question…
-
Submitting a sample: the process end to end Replied, post #82 · Sourcing › Independent verification · 14 Jul 2026 · 0 likes Where I part company with post #79, and it is a narrow parting. Submitting a sample came up in a thread eighteen months ago and was answered well. I cannot find it,…
-
Isotope patterns and why the monoisotopic peak is not the tallest — does this still hold? Replied, post #2 · Analytics › Mass spectrometry · 9 Jul 2026 · 31 likes Monoisotopic and average mass are different numbers and both appear on documents. At this molecular weight the difference is a few daltons, which is more than the…
-
Interim analyses and stopping rules Replied, post #29 · Evidence › Trials · 4 Jul 2026 · 0 likes Noted, and thank you for writing it out rather than summarising it.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #106 · Practice › Reconstitution · 1 Jul 2026 · 8 likes Post #102 put the caveat in the right place and I want to underline it. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #2 · Start Here › Welcome · 30 Jun 2026 · 22 likes For anyone finding this later: the short answer on Reading order is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
What a reversed-phase purity number actually is Replied, post #7 · Analytics › HPLC & UHPLC · 27 Jun 2026 · 1 like Coming back to post #3, because the follow-up matters more than the original answer. Summarising the reversed-phase purity number thread so far, since it is long and…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #80 · Practice › Administration · 25 Jun 2026 · 26 likes The practical version of Pinch is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
A critique that turned out to be unfair, retracted by its author Replied, post #14 · Evidence › Study critique · 17 Jun 2026 · 31 likes Taking post #13 at face value and following it one step further. Where a critique changes your position, saying so in the thread is worth more than being right, and it…
-
Injecting into an area that has become firm: why not to Replied, post #80 · Practice › Administration · 15 Jun 2026 · 0 likes Post #78 describes the usual case. This is about the unusual one. If you have to inject at a different time of day than usual, that is a much smaller perturbation than…
-
Reading a home test result without over-claiming Replied, post #80 · Analytics › Home & field testing · 15 Jun 2026 · 6 likes Quantitation at home is the part that does not survive scrutiny. Precision adequate to distinguish 96 from 98 per cent requires instrumentation and calibration that a…
-
Micronutrient adequacy at low total intake Replied, post #49 · Nutrition & Training › Protein & intake · 10 Jun 2026 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
Programming during a large energy deficit Replied, post #13 · Nutrition & Training › Resistance training · 8 Jun 2026 · 0 likes Maintenance phases are where most people report training going best, which is unsurprising and is worth saying to anybody struggling during loss.
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #45 · Analytics › Home & field testing · 8 Jun 2026 · 7 likes A note on scope: what I am saying about Reflectance and photometric devices applies to the case in the first post and I would not extend it further without checking.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #104 · Sourcing › Red flags · 7 Jun 2026 · 28 likes Post #102 describes the usual case. This is about the unusual one. An unexplained discrepancy that the supplier declined to address is a legitimate thing to record,…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #9 · Access › Insurance & coverage · 6 Jun 2026 · 10 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Programming during a large energy deficit Replied, post #10 · Nutrition & Training › Resistance training · 4 Jun 2026 · 32 likes Adding a data point of agreement rather than a data point.
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #13 · Evidence › Journal club · 2 Jun 2026 · 20 likes Agreed on all of that, and I have nothing to add to it.
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #68 · Practice › Storage & stability · 2 Jun 2026 · 8 likes I think the Mean kinetic temperature question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Coming back to: Time to steady state after a dose increase Replied, post #65 · Pharmacology › Pharmacokinetics · 30 May 2026 · 3 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Electrolyte supplements: which ones do anything Replied, post #18 · Nutrition & Training › Hydration & electrolytes · 28 May 2026 · 0 likes The interaction between electrolyte handling and other medicines is a pharmacist question and is answered quickly. Written in the hope of being told what I have missed.
-
Fasting versus non-fasting and which tests care Replied, post #37 · Clinical › Bloodwork · 28 May 2026 · 27 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason.
-
Second pass at: Programming during a large energy deficit Replied, post #4 · Nutrition & Training › Resistance training · 27 May 2026 · 7 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
-
Revisiting: Patterns that reliably precede a problem, documented Replied, post #16 · Sourcing › Red flags · 22 May 2026 · 10 likes Claims of pharmaceutical-grade status for research-use-only material are a labelling problem and are common enough to be worth expecting rather than reacting to. It is…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #6 · Sourcing › Vendor reports · 20 May 2026 · 9 likes Where you have no independent result, a documentation report is still worth filing: what the certificate contained, what it omitted, and how fast a request was answered.
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #17 · Research Methods › N-of-1 designs · 16 May 2026 · 22 likes Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1.…
-
CJC-1295 with and without DAC: what the modification does Replied, post #54 · Compounds › Secretagogues & GH axis · 11 May 2026 · 7 likes Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
-
The "under review" status pill and when a moderator applies it Replied, post #110 · Evidence › Preprints · 2 May 2026 · 0 likes Confirming post #108 from a second method, which matters more than confirming it from a second person. A preprint with the data and code attached is frequently more…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #25 · Wellbeing › Sleep · 1 May 2026 · 22 likes A sleep diary with times rather than impressions is the only way to tell a real change from a remembered one, and it takes a minute a day. I would want to see it done…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #132 · Practice › Reconstitution · 26 Apr 2026 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
The "under review" status pill and when a moderator applies it Replied, post #90 · Evidence › Preprints · 23 Apr 2026 · 0 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.…
-
Journal club: is percentage weight change the right endpoint? Replied, post #88 · Evidence › Journal club · 21 Apr 2026 · 4 likes Narrowing post #86, because the general version has more than one answer. The figures usually contain the finding and the text usually contains the interpretation.…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #84 · Practice › Interactions · 12 Apr 2026 · 22 likes Anyone asking an interaction question should list everything, including the things they consider irrelevant. The irrelevant one is the answer more often than chance…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #8 · Safety › Contraindications · 11 Apr 2026 · 0 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #90 · Sourcing › Vendor reports · 4 Apr 2026 · 1 like Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #133 · Access › Pricing · 1 Apr 2026 · 2 likes Everything in post #131 holds. The case it does not cover is the one I have. Adding a small correction to the Price changes summary above rather than a disagreement…
-
When a dose reduction is the correct response to a side effect Replied, post #9 · Practice › Dosing & titration · 31 Mar 2026 · 2 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #40 · Practice › Interactions · 28 Mar 2026 · 7 likes Absence of an interaction study is not evidence of no interaction. A great many combinations discussed here have simply never been studied, and saying so is more useful…
-
Second pass at: Why chargeback is not the safety net people assume Started this topic · Sourcing › Payments · 20 Mar 2026 · 57 likes Second pass at: Why chargeback is not the safety net people assume Writing it up because I had to work it out twice and would rather nobody else did. Asking about the…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #70 · Practice › Reconstitution · 19 Mar 2026 · 17 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #14 · Compounds › Repair & healing peptides · 17 Mar 2026 · 5 likes Taking post #12 at face value and following it one step further. Analytical identity of BPC-157 would be much easier to settle if anyone reported the denominator.…
-
Managing an unplanned gap in supply Replied, post #63 · Access › Shortages · 16 Mar 2026 · 0 likes What I would check first on managing an unplanned gap is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
Moderation log format change Replied, post #35 · Meta › Announcements · 11 Mar 2026 · 25 likes I had written a reply contradicting post #31 and deleted it. Here is what survived. One question about the transition rather than the policy: what happens to topics…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #38 · Outcomes › Body composition · 8 Mar 2026 · 32 likes Photographs under fixed lighting and posture are a genuine record and are the hardest of these to standardise.
-
[2026 update] Availability by country, dated, with primary sources Replied, post #30 · Access › International · 22 Feb 2026 · 32 likes No notes. Posting so the count is not one.
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #53 · Practice › Side effects · 17 Jan 2026 · 0 likes Building on post #50 rather than restating it. Source for the muscle cramps figure, since it was asked for. It is in the discussion rather than the abstract, which is…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #41 · Documentation › Wiki requests · 16 Jan 2026 · 2 likes Worth separating two things that post #38 runs together. Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a…
-
What to include when your question involves a chromatogram Replied, post #43 · Start Here › How to Ask · 14 Jan 2026 · 15 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
A partial dose because the pen emptied mid-injection Replied, post #121 · Practice › Administration · 11 Jan 2026 · 7 likes Note the site alongside the dose. If a local reaction appears three weeks later you will want to know where the previous four injections went.
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #111 · Compounds › Oral incretins · 26 Dec 2025 · 4 likes Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of magnitude different from the injectable. That is a formulation…
-
Reading SURMOUNT-1 without the press release Replied, post #112 · Compounds › Tirzepatide · 23 Dec 2025 · 2 likes Everything in post #111 holds. The case it does not cover is the one I have. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #44 · Start Here › How to Ask · 21 Dec 2025 · 2 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #63 · Wellbeing › Mental health · 15 Dec 2025 · 27 likes When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function, involving a mental health professional is appropriate.…
-
Reading an interaction checker output critically Replied, post #51 · Practice › Interactions · 25 Nov 2025 · 2 likes Where the reading an interaction checker output reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #2 · Compounds › Other compounds · 21 Nov 2025 · 13 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #13 · Clinical › Bloodwork · 19 Nov 2025 · 0 likes Coming back to post #11, because the follow-up matters more than the original answer. Where a panel includes a calculated value, that value inherits the imprecision of…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #9 · Practice › Interactions · 17 Nov 2025 · 0 likes Small methodological point on Common supplements: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
The headache that turns out to be dehydration Replied, post #48 · Nutrition & Training › Hydration & electrolytes · 7 Nov 2025 · 24 likes Understood, and I withdraw the assumption I opened with.
-
High-resolution MS on aggregates and what it can see Replied, post #104 · Analytics › Mass spectrometry · 27 Oct 2025 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed high-resolution, as opposed to read about it? The thread is long and I cannot tell.
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #114 · Compounds › Tirzepatide · 24 Oct 2025 · 12 likes On post #112 — agreed on the reasoning, with one qualification. Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are…
-
Adolescents: a distinct evidence base — one year on Replied, post #24 · Clinical › Special populations · 12 Oct 2025 · 0 likes Coming back to post #20, because the follow-up matters more than the original answer. Athletes and people in substantial training loads are effectively unstudied, and…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #122 · Practice › Side effects · 5 Oct 2025 · 1 like A symptom that starts weeks after a dose has been stable is a different observation from one that starts after an escalation, and it deserves a different explanation.…
-
Insomnia at a dose step: reported experiences Replied, post #11 · Wellbeing › Sleep · 16 Sep 2025 · 0 likes On post #7 — agreed on the reasoning, with one qualification. An honest declaration on insomnia: I have a prior here and it is strong enough that you should weight what…
-
How to ask about something you suspect is a bad idea Replied, post #7 · Start Here › How to Ask · 7 Sep 2025 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. That is where I would start, not where…
-
When a preprint is the best available evidence and we say so Replied, post #93 · Evidence › Preprints · 24 Aug 2025 · 1 like A preprint with the data and code attached is frequently more checkable than a published paper without them. Reviewed and reproducible are different properties. If that…
-
Foaming during reconstitution and whether it matters Replied, post #23 · Practice › Reconstitution · 13 Aug 2025 · 9 likes The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume, then volume per dose — and see whether they agree. They…
-
What a documentation review can and cannot tell you Replied, post #61 · Sourcing › Independent verification · 5 Aug 2025 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Triple agonism: additive, synergistic, or neither? Replied, post #75 · Compounds › Retatrutide · 3 Aug 2025 · 0 likes Picking up post #73: that is the part I would want checked first. The hepatic-steatosis rationale follows directly from glucagon receptor agonism promoting fat…
-
Needle changes between doses on a reusable pen Replied, post #22 · Devices › Pens & autoinjectors · 21 Jul 2025 · 26 likes Understood. Thank you for being specific about the limits of it.
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #3 · Compounds › Other compounds · 19 Jul 2025 · 0 likes Two people in this thread mean different things by catalogue breadth and are disagreeing about the definition while believing they are disagreeing about the facts.…
-
Coming back to: When "no data" is the complete and final answer Replied, post #48 · Compounds › Other compounds · 17 Jul 2025 · 12 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #78 · Evidence › Trials · 15 Jul 2025 · 14 likes Coming back to post #75, because the follow-up matters more than the original answer. Before the thread moves on from Comparators chosen for regulatory reasons — what…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #38 · Analytics › Method validation · 13 Jul 2025 · 0 likes Where I part company with post #36, and it is a narrow parting. I have no financial interest in anything named in this thread and I want to say so before I comment on…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #15 · Pharmacology › Receptor biology · 11 Jul 2025 · 0 likes Post #12 answers the question as asked. The question underneath it is different. An update on my earlier GLP-1 receptor distribution post: the pattern held for another…
-
Revisiting: Food effects on oral incretin absorption: what is documented Replied, post #7 · Compounds › Oral incretins · 5 Jul 2025 · 9 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Titles that describe the question, not the situation Replied, post #35 · Start Here › How to Ask · 25 Jun 2025 · 22 likes Fair, and the limits you put on it are the part I will remember.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #115 · Access › Insurance & coverage · 14 Jun 2025 · 0 likes Where an exception process exists separately from an appeal, they are different routes with different criteria and using the wrong one loses time.
-
Pre-registering a personal experiment, seriously Replied, post #25 · Research Methods › N-of-1 designs · 27 May 2025 · 13 likes I read post #23 twice before replying, because I had assumed the opposite. The most useful thing anyone has posted about pre-registering a personal experiment in this…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #86 · Data & Tools › Calculators · 23 May 2025 · 0 likes I would keep Validating a calculator against hand and the decision it usually gets used for separate in this thread. They are related and they are not the same…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #7 · Sourcing › Regulatory · 18 May 2025 · 3 likes Picking up post #6: that is the part I would want checked first. Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials.…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #102 · Access › Pricing · 16 May 2025 · 9 likes Cost per milligram is the only comparison that survives format differences, and even then it needs care.
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #3 · Analytics › Method validation · 16 May 2025 · 19 likes A method that reports the same number for every lot is worth a second look. Real processes vary, and a total absence of variation is a statement about the measurement…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #101 · Practice › Reconstitution · 9 May 2025 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #24 · Practice › Dosing & titration · 1 May 2025 · 9 likes Post #22 put the caveat in the right place and I want to underline it. I would keep Escalating every six weeks instead and the decision it usually gets used for…
-
A report I filed that turned out to be wrong, and the correction Replied, post #35 · Sourcing › Vendor reports · 1 May 2025 · 0 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide.
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #59 · Devices › Syringes & needles · 25 Apr 2025 · 0 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
-
Foaming during reconstitution and whether it matters Replied, post #10 · Practice › Reconstitution · 22 Apr 2025 · 4 likes Worth separating two things that post #7 runs together. The reason foaming during reconstitution is hard to answer is that the obvious measurement and the relevant…
-
Research-use-only status: what it means legally and practically — does this still hold? Started this topic · Compounds › Other compounds · 7 Apr 2025 · 21 likes Asking directly, because I could not find a straight answer: Research-use-only status: what it means legally and practically — does this still hold? Asking about…
-
Deamidation and the close-eluting pair it produces Replied, post #20 · Analytics › Impurities & related substances · 5 Apr 2025 · 2 likes Genuine question rather than a rhetorical one: has anyone here actually observed deamidation, as opposed to read about it? The thread is long and I cannot tell.
-
Triple agonism: additive, synergistic, or neither? Replied, post #31 · Compounds › Retatrutide · 29 Mar 2025 · 0 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #121 · Compounds › Other compounds · 21 Mar 2025 · 0 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #68 · Sourcing › Red flags · 20 Mar 2025 · 0 likes A stock listing that never changes and a lead time that never varies are both worth noticing. Real operations have variation in them. Adding it because I spent an…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #58 · Documentation › Doc review · 14 Mar 2025 · 1 like Noted, and I have changed what I was going to do on the strength of it.
-
Requesting a page: what makes a good request Replied, post #14 · Documentation › Wiki requests · 5 Mar 2025 · 0 likes On post #12 — agreed on the reasoning, with one qualification. Say what would make the page wrong. A page whose failure conditions are stated is much easier to review…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #57 · Access › International · 21 Feb 2025 · 0 likes A regional experience posted here should say which year it describes. The archive keeps these permanently and they age faster than anything else on the site. A weak…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #55 · Evidence › Meta-analyses · 5 Feb 2025 · 12 likes A note on scope: what I am saying about Random versus fixed effects applies to the case in the first post and I would not extend it further without checking.
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #79 · Analytics › COA interpretation · 29 Jan 2025 · 14 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #33 · Pharmacology › Receptor biology · 24 Jan 2025 · 2 likes Cross-reactivity at related receptors within the secretin family is real and is one reason selectivity claims should be read against the panel that was tested rather…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #37 · Sourcing › Red flags · 10 Jan 2025 · 10 likes The most useful contribution to this subcategory is a resolved case written up with the resolution, because the unresolved ones are all anyone remembers. I would put…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #31 · Data & Tools › Calculators · 26 Dec 2024 · 18 likes Significant figures in the output should not exceed what the inputs support. A concentration calculated from a nominal vial mass is not known to four decimal places.
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #121 · Practice › Dosing & titration · 8 Dec 2024 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
Second pass at: Domestic fridge temperature mapping: a cheap experiment Started this topic · Devices › Cold chain · 7 Dec 2024 · 0 likes Posting this under the heading it deserves: Second pass at: Domestic fridge temperature mapping: a cheap experiment Everything below is what sits behind that. Two…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #38 · Clinical › Special populations · 6 Dec 2024 · 6 likes Post #37 answers the question as asked. The question underneath it is different. Nothing in this subcategory is medical advice and the questions asked here are…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #58 · Clinical › Special populations · 24 Nov 2024 · 4 likes Taking Type 1 diabetes seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those…
-
Telehealth prescribing models in the US Replied, post #25 · Regional › North America · 21 Nov 2024 · 19 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Coming back to: Why the cheapest option is often not the cheapest Replied, post #3 · Access › Pricing · 19 Nov 2024 · 0 likes The most useful pricing posts here are the ones that show the arithmetic rather than the conclusion.
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #65 · Clinical › Prescriber conversations · 15 Nov 2024 · 1 like Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #20 · Compounds › Cagrilintide & amylin analogues · 8 Nov 2024 · 0 likes The interest in combining it with semaglutide is that two different satiety mechanisms might add. Whether they do, and by how much, is exactly what the combination…
-
Promotion criteria, and the one that stops most nominations Replied, post #105 · Documentation › Doc review · 6 Nov 2024 · 1 like Promotion criteria has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Telehealth prescribing models in the US Replied, post #18 · Regional › North America · 1 Nov 2024 · 19 likes Emotional language in an appeal does not help, however justified it is. The reviewer is checking criteria and the job is to make them checkable. That is the shape of…
-
Why I ask for the gradient before I discuss the number Replied, post #32 · Analytics › HPLC & UHPLC · 31 Oct 2024 · 0 likes Worth separating two things that post #28 runs together. Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer…
-
Buffers, pH and why a formulation is a formulation Replied, post #5 · Pharmacology › Formulation chemistry · 26 Oct 2024 · 0 likes The arithmetic on buffers is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
Irish differences from the UK position Replied, post #46 · Regional › UK & Ireland · 19 Oct 2024 · 0 likes The version of irish differences that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #15 · Compounds › Secretagogues & GH axis · 11 Oct 2024 · 0 likes This follows post #12 rather than contradicting it. Source for the pulsatile secretion figure, since it was asked for. It is in the discussion rather than the abstract,…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #116 · Nutrition & Training › Hydration & electrolytes · 26 Sep 2024 · 0 likes Narrowing post #113, because the general version has more than one answer. Supplementing without measuring is the default approach described here and it carries its own…
-
Converting between mg/mL and units per dose, both directions Replied, post #27 · Practice › Reconstitution · 22 Sep 2024 · 1 like Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #43 · Analytics › Impurities & related substances · 7 Sep 2024 · 28 likes A supplier that can tell you what its principal impurity is has answered a harder question than one that can tell you its purity, and the answer is more useful. I am…
-
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #23 · Compounds › Oral incretins · 30 Aug 2024 · 27 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
-
Correlation in a self-tracked dataset: what it can support Replied, post #14 · Research Methods › Statistics · 20 Aug 2024 · 9 likes No disagreement from me. Posting only so the question does not look ignored.
-
Promotion criteria, and the one that stops most nominations Replied, post #29 · Documentation › Doc review · 1 Aug 2024 · 19 likes A request rather than an answer: could whoever has the primary source for promotion criteria post it? I have seen the claim three times this month and each version had…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #19 · Evidence › Journal club · 12 Jul 2024 · 13 likes Post #17 describes the usual case. This is about the unusual one. Where I would push back on the LEADER consensus is the confidence, not the direction. The direction…